Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Gilbert

Showing results (131-140 of 173) with videos related to

Pageof 18
Sort By:
Diabetes Care|January 19, 2007
Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetesRichard E Gilbert, Sandra A Kim, Katherine R Tuttle, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 22, 2009
Protein kinase C-beta inhibition attenuates the progression of nephropathy in non-diabetic kidney diseaseDarren J Kelly, Amanda J Edgley, Yuan Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2013
3',4'-Bis-difluoromethoxycinnamoylanthranilate (FT061): an orally-active antifibrotic agent that reduces albuminuria in a rat model of progressive diabetic nephropathySpencer J Williams, Steven C Zammit, Alison J Cox, et al.
International Journal of Cardiology|June 23, 2005
Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-upAndrew J Boyle, Robert Whitbourn, Stephen Schlicht, et al.
Journal of Hypertension|April 21, 2011
The cardiac (pro)renin receptor is primarily expressed in myocyte transverse tubules and is increased in experimental diabetic cardiomyopathyKim A Connelly, Andrew Advani, Sandra Kim, et al.
Plos One|October 11, 2011
Fluorescent microangiography is a novel and widely applicable technique for delineating the renal microvasculatureAndrew Advani, Kim A Connelly, Darren A Yuen, et al.
Cardiovascular Drugs and Therapy|September 29, 2022
The SGLT2i Dapagliflozin Reduces RV Mass Independent of Changes in RV Pressure Induced by Pulmonary Artery BandingKim A Connelly, Ellen Wu, Aylin Visram, et al.
European Journal of Heart Failure|March 16, 2012
FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathyYuan Zhang, Amanda J Edgley, Alison J Cox, et al.
Plos One|March 19, 2014
SDF-1/CXCR4 signaling preserves microvascular integrity and renal function in chronic kidney diseaseLi-Hao Chen, Suzanne L Advani, Kerri Thai, et al.
Hypertension (Dallas, Tex. : 1979)|June 24, 2009
The (Pro)renin receptor: site-specific and functional linkage to the vacuolar H+-ATPase in the kidneyAndrew Advani, Darren J Kelly, Alison J Cox, et al.
Pageof 18

Showing results (131-140 of 173) with videos related to

Sort By:
Pageof 18
Diabetes Care|January 19, 2007
Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetesRichard E Gilbert, Sandra A Kim, Katherine R Tuttle, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 22, 2009
Protein kinase C-beta inhibition attenuates the progression of nephropathy in non-diabetic kidney diseaseDarren J Kelly, Amanda J Edgley, Yuan Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2013
3',4'-Bis-difluoromethoxycinnamoylanthranilate (FT061): an orally-active antifibrotic agent that reduces albuminuria in a rat model of progressive diabetic nephropathySpencer J Williams, Steven C Zammit, Alison J Cox, et al.
International Journal of Cardiology|June 23, 2005
Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-upAndrew J Boyle, Robert Whitbourn, Stephen Schlicht, et al.
Journal of Hypertension|April 21, 2011
The cardiac (pro)renin receptor is primarily expressed in myocyte transverse tubules and is increased in experimental diabetic cardiomyopathyKim A Connelly, Andrew Advani, Sandra Kim, et al.
Plos One|October 11, 2011
Fluorescent microangiography is a novel and widely applicable technique for delineating the renal microvasculatureAndrew Advani, Kim A Connelly, Darren A Yuen, et al.
Cardiovascular Drugs and Therapy|September 29, 2022
The SGLT2i Dapagliflozin Reduces RV Mass Independent of Changes in RV Pressure Induced by Pulmonary Artery BandingKim A Connelly, Ellen Wu, Aylin Visram, et al.
European Journal of Heart Failure|March 16, 2012
FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathyYuan Zhang, Amanda J Edgley, Alison J Cox, et al.
Plos One|March 19, 2014
SDF-1/CXCR4 signaling preserves microvascular integrity and renal function in chronic kidney diseaseLi-Hao Chen, Suzanne L Advani, Kerri Thai, et al.
Hypertension (Dallas, Tex. : 1979)|June 24, 2009
The (Pro)renin receptor: site-specific and functional linkage to the vacuolar H+-ATPase in the kidneyAndrew Advani, Darren J Kelly, Alison J Cox, et al.
Pageof 18